<div class= "panel-pane pane-entity-field pane-node-field-article-summary"> <div class="pane-content"> <div> <p>In this edition of the “Peer to Peer” audiocast series, Dr. Vincent DeLeo speaks with Dr. Steven Feldman about treatment compliance and addressing patient concerns about treatment safety data. They discuss strategies for reassuring patients about risks associated with biologics for psoriasis and other drugs, particularly risks patients may read about on the Internet.</p> </div> </div> </div>

In this edition of the “Peer to Peer” audiocast series, Dr. Vincent DeLeo speaks with Dr. Steven Feldman about treatment compliance and addressing patient concerns about treatment safety data. They discuss strategies for reassuring patients about risks associated with biologics for psoriasis and other drugs, particularly risks patients may read about on the Internet.

   <p>In this edition of the “Peer to Peer” audiocast series, Dr. Vincent DeLeo speaks with Dr. Steven Feldman about treatment compliance and addressing patient concerns about treatment safety data. They discuss strategies for reassuring patients about risks associated with biologics for psoriasis and other drugs, particularly risks patients may read about on the Internet.</p>   

Addressing Patient Concerns About Treatment Safety Data

Official Podcast feed of MDedge Dermatology and Cutis Peer-to-Peer, part of the Medscape Professional Network. Weekly episodes include the latest in Dermatology News and peer-to-peer interviews with Doctor Vincent A. DeLeo, MD, and Dr. Candrice Heath, MD. Plus, resident discussions geared toward physicians-in-training. The information in this podcast is provided for informational and educational purposes only.

Share Addressing Patient Concerns About Treatment Safety Data

Sign up to save your podcasts

Addressing Patient Concerns About Treatment Safety Data

Addressing Patient Concerns About Treatment Safety Data